Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? Reply

Authors
Boeckh, M Gooley, T Leisenring, W Myerson, D Corey, L
Citation
M. Boeckh et al., Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? Reply, J INFEC DIS, 180(2), 1999, pp. 572-574
Citations number
7
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
180
Issue
2
Year of publication
1999
Pages
572 - 574
Database
ISI
SICI code
0022-1899(199908)180:2<572:DHPAAB>2.0.ZU;2-L